IP Library › Assignment 044039/0329
Patent Assignment
Reel/Frame 044039/0329

Certificate of Conversion

Recorded: 2017-09-26 Pages: 9
Assignor
AROG PHARMACEUTICALS, LLC
Executed: 2014-09-13
Assignee
AROG PHARMACEUTICALS, INC.
5420 LBJ FREEWAY, SUITE 410, DALLAS, TEXAS, 75240
Covered Properties (2)
Method of Inhibiting Constitutively Active Phosphorylated FLT3 Kinase
Application: 15/715,219 →
Publication: US 2018/0055834
Crenolanib for Treating FLT3 Mutated Proliferative Disorders
Application: 15/715,274 →
Publication: US 2018/0015081
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 26, 2017
From: JAIN, VINAY K.
To: AROG PHARMACEUTICALS, LLC
Reel/Frame 043692/0926 →
Assignment of Assignor's Interest Sep 26, 2017
From: JAIN, VINAY K.
To: AROG PHARMACEUTICALS, LLC
Reel/Frame 043691/0436 →